T1	AdverseReaction 74 88	hepatotoxicity
T2	AdverseReaction 68 73	Fatal
T3	AdverseReaction 241 266	Interstitial Lung Disease
T4	AdverseReaction 268 271	ILD
T5	AdverseReaction 273 284	Pneumonitis
T6	AdverseReaction 389 413	QT Interval Prolongation
T7	AdverseReaction 731 742	bradycardia
T8	Factor 721 724	can
T9	AdverseReaction 885 896	Visual Loss
T11	AdverseReaction 1072 1082	fetal harm
T12	Factor 1062 1065	Can
T13	AdverseReaction 1270 1284	hepatotoxicity
T14	AdverseReaction 1290 1295	fatal
T15	AdverseReaction 1425 1463	elevations in alanine aminotransferase
T16	AdverseReaction 1425 1438;1465 1468	elevations in ALT
T17	AdverseReaction 1425 1438;1473 1499	elevations in aspartate aminotransferase
T18	AdverseReaction 1425 1438;1501 1504	elevations in AST
T19	Severity 1531 1574	three times the upper limit of normal (ULN)
T20	AdverseReaction 1579 1594;1620 1637	total bilirubin two times the ULN
T21	AdverseReaction 1740 1757	elevations in ALT
T22	AdverseReaction 1740 1753;1761 1764	elevations in AST
T23	Severity 1778 1796	five times the ULN
T24	AdverseReaction 1925 1947	elevated transaminases
T25	AdverseReaction 1949 1972	Transaminase elevations
T26	AdverseReaction 2623 2648	interstitial lung disease
T27	AdverseReaction 2617 2622	fatal
T28	Severity 2596 2612	life-threatening
T29	Severity 2588 2594	Severe
T30	AdverseReaction 2650 2653	ILD
T31	AdverseReaction 2655 2666	pneumonitis
T32	Factor 2667 2670	can
T33	AdverseReaction 2783 2786	ILD
T34	AdverseReaction 2837 2840	ILD
T35	AdverseReaction 2874 2877	ILD
T36	AdverseReaction 2868 2873	fatal
T37	Severity 2824 2831	Grade 3
T38	Severity 2824 2829;2835 2836	Grade 4
T39	AdverseReaction 3293 3309	QTc prolongation
T40	Factor 3310 3313	can
T41	AdverseReaction 3409 3413;3454 3485	QTcF greater than or equal to 500 ms
T42	AdverseReaction 3524 3532;3547 3551	increase QTcF
T43	Severity 3577 3582	60 ms
T44	AdverseReaction 4498 4521	Symptomatic bradycardia
T45	AdverseReaction 4587 4598	bradycardia
T46	AdverseReaction 4700 4740	heart rate less than 50 beats per minute
T47	AdverseReaction 4770 4777	syncope
T48	Severity 4762 4769	Grade 3
T49	AdverseReaction 5914 5933	visual field defect
T50	AdverseReaction 5939 5950	vision loss
T51	Severity 5906 5913	Grade 4
T52	AdverseReaction 5970 5983	Optic atrophy
T53	AdverseReaction 5988 6008	optic nerve disorder
T54	AdverseReaction 6051 6062	vision loss
T55	Factor 6031 6040	potential
T56	AdverseReaction 6730 6740	fetal harm
T57	Factor 6720 6723	can
T58	AdverseReaction 6975 6989	embryotoxicity
T59	AdverseReaction 6994 7006	fetotoxicity
T61	Animal 6858 6862	rats
T60	AdverseReaction 52 66	Hepatotoxicity
T62	AdverseReaction 700 711	Bradycardia
T63	AdverseReaction 1040 1060	Embryofetal Toxicity
T10	Severity 878 884	Severe
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7 Hypothetical:E8
E8	Factor:T8
E9	AdverseReaction:T9 Effect:E10
E11	AdverseReaction:T11 Hypothetical:E12
E12	Factor:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14
E15	AdverseReaction:T15 Effect:E19
E16	AdverseReaction:T16 Effect:E19
E17	AdverseReaction:T17 Effect:E19
E18	AdverseReaction:T18 Effect:E19
E19	Severity:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21 Effect:E23
E22	AdverseReaction:T22 Effect:E23
E23	Severity:T23
E24	AdverseReaction:T24
E25	AdverseReaction:T25
E26	AdverseReaction:T26 Effect:E29 Effect2:E28 Hypothetical:E32
E27	AdverseReaction:T27 Hypothetical:E32
E28	Severity:T28
E29	Severity:T29
E30	AdverseReaction:T30 Effect:E28 Effect2:E29 Hypothetical:E32
E31	AdverseReaction:T31 Effect:E28 Effect2:E29 Hypothetical:E32
E32	Factor:T32
E33	AdverseReaction:T33
E34	AdverseReaction:T34 Effect:E38 Effect2:E37
E35	AdverseReaction:T35
E36	AdverseReaction:T36
E37	Severity:T37
E38	Severity:T38
E39	AdverseReaction:T39 Hypothetical:E40
E40	Factor:T40
E41	AdverseReaction:T41
E42	AdverseReaction:T42 Effect:E43
E43	Severity:T43
E44	AdverseReaction:T44
E45	AdverseReaction:T45
E46	AdverseReaction:T46
E47	AdverseReaction:T47 Effect:E48
E48	Severity:T48
E49	AdverseReaction:T49 Effect:E51
E50	AdverseReaction:T50 Effect:E51
E51	Severity:T51
E52	AdverseReaction:T52 Hypothetical:E55
E53	AdverseReaction:T53 Hypothetical:E55
E54	AdverseReaction:T54
E55	Factor:T55
E56	AdverseReaction:T56 Hypothetical:E57
E57	Factor:T57
E58	AdverseReaction:T58 Hypothetical:E61
E59	AdverseReaction:T59 Hypothetical:E61
E61	Animal:T61
E60	AdverseReaction:T31 Hypothetical:E32
E62	AdverseReaction:T30 Hypothetical:E32
E63	AdverseReaction:T26 Hypothetical:E32
E64	AdverseReaction:T60
E65	AdverseReaction:T62
E66	AdverseReaction:T63
E10	Severity:T10
A1	CUI E1 C0235378
A2	UMLS-Preferred-Name E1 Hepatotoxicity
A3	MEDDRA-PT E1 Hepatotoxicity
A4	MEDDRA-PT-ID E1 10019851
A5	CUI E2 C1306577
A6	UMLS-Preferred-Name E2 Death (finding)
A7	MEDDRA-PT E2 Death
A8	MEDDRA-PT-ID E2 10011906
A9	CUI E3 C0206062
A10	UMLS-Preferred-Name E3 Lung Diseases, Interstitial
A11	MEDDRA-PT E3 Interstitial lung disease
A12	MEDDRA-PT-ID E3 10022611
A13	CUI E4 C0206062
A14	UMLS-Preferred-Name E4 Lung Diseases, Interstitial
A15	MEDDRA-PT E4 Interstitial lung disease
A16	MEDDRA-PT-ID E4 10022611
A17	CUI E5 C3714636
A18	UMLS-Preferred-Name E5 Pneumonitis
A19	MEDDRA-PT E5 Pneumonitis
A20	MEDDRA-PT-ID E5 10035742
A21	CUI E6 C0151878
A22	UMLS-Preferred-Name E6 Prolonged QT interval
A23	MEDDRA-PT E6 Electrocardiogram QT prolonged
A24	MEDDRA-PT-ID E6 10014387
A25	LLT E6 QT interval prolonged
A26	LLT-ID E6 10037703
A27	CUI E7 C0428977
A28	UMLS-Preferred-Name E7 Bradycardia
A29	MEDDRA-PT E7 Bradycardia
A30	MEDDRA-PT-ID E7 10006093
A31	CUI E9 C3665386
A32	UMLS-Preferred-Name E9 Abnormal vision
A33	MEDDRA-PT E9 Blindness
A34	MEDDRA-PT-ID E9 10005169
A35	LLT E9 Vision loss
A36	LLT-ID E9 10047522
A37	CUI E11 C0854268
A38	UMLS-Preferred-Name E11 Foetal damage
A39	MEDDRA-PT E11 Foetal damage
A40	MEDDRA-PT-ID E11 10016852
A41	LLT E11 Fetal damage
A42	LLT-ID E11 10054743
A43	CUI E13 C0235378
A44	UMLS-Preferred-Name E13 Hepatotoxicity
A45	MEDDRA-PT E13 Hepatotoxicity
A46	MEDDRA-PT-ID E13 10019851
A47	CUI E14 C1306577
A48	UMLS-Preferred-Name E14 Death (finding)
A49	MEDDRA-PT E14 Death
A50	MEDDRA-PT-ID E14 10011906
A51	CUI E15 C0151905
A52	UMLS-Preferred-Name E15 Alanine aminotransferase increased
A53	MEDDRA-PT E15 Alanine aminotransferase increased
A54	MEDDRA-PT-ID E15 10001551
A55	CUI E16 C0151905
A56	UMLS-Preferred-Name E16 Alanine aminotransferase increased
A57	MEDDRA-PT E16 Alanine aminotransferase increased
A58	MEDDRA-PT-ID E16 10001551
A59	LLT E16 ALT increased
A60	LLT-ID E16 10001845
A61	CUI E17 C0151904
A62	UMLS-Preferred-Name E17 Aspartate aminotransferase increased
A63	MEDDRA-PT E17 Aspartate aminotransferase increased
A64	MEDDRA-PT-ID E17 10003481
A65	CUI E18 C0151904
A66	UMLS-Preferred-Name E18 Aspartate aminotransferase increased
A67	MEDDRA-PT E18 Aspartate aminotransferase increased
A68	MEDDRA-PT-ID E18 10003481
A69	LLT E18 AST increased
A70	LLT-ID E18 10003544
A71	CUI E20 C0741494
A72	UMLS-Preferred-Name E20 Elevated total bilirubin
A73	MEDDRA-PT E20 Blood bilirubin increased
A74	MEDDRA-PT-ID E20 10005364
A75	LLT E20 Bilirubin total increased
A76	LLT-ID E20 10056806
A77	CUI E21 C0151905
A78	UMLS-Preferred-Name E21 Alanine aminotransferase increased
A79	MEDDRA-PT E21 Alanine aminotransferase increased
A80	MEDDRA-PT-ID E21 10001551
A81	LLT E21 ALT increased
A82	LLT-ID E21 10001845
A83	CUI E22 C0151904
A84	UMLS-Preferred-Name E22 Aspartate aminotransferase increased
A85	MEDDRA-PT E22 Aspartate aminotransferase increased
A86	MEDDRA-PT-ID E22 10003481
A87	LLT E22 AST increased
A88	LLT-ID E22 10003544
A89	CUI E24 C0438717
A90	UMLS-Preferred-Name E24 Transaminases increased
A91	MEDDRA-PT E24 Transaminases increased
A92	MEDDRA-PT-ID E24 10054889
A93	CUI E25 C0438717
A94	UMLS-Preferred-Name E25 Transaminases increased
A95	MEDDRA-PT E25 Transaminases increased
A96	MEDDRA-PT-ID E25 10054889
A97	CUI E26 C0206062
A98	UMLS-Preferred-Name E26 Lung Diseases, Interstitial
A99	MEDDRA-PT E26 Interstitial lung disease
A100	MEDDRA-PT-ID E26 10022611
A101	CUI E27 C1306577
A102	UMLS-Preferred-Name E27 Death (finding)
A103	MEDDRA-PT E27 Death
A104	MEDDRA-PT-ID E27 10011906
A105	CUI E30 C0206062
A106	UMLS-Preferred-Name E30 Lung Diseases, Interstitial
A107	MEDDRA-PT E30 Interstitial lung disease
A108	MEDDRA-PT-ID E30 10022611
A109	CUI E31 C3714636
A110	UMLS-Preferred-Name E31 Pneumonitis
A111	MEDDRA-PT E31 Pneumonitis
A112	MEDDRA-PT-ID E31 10035742
A113	CUI E33 C0206062
A114	UMLS-Preferred-Name E33 Lung Diseases, Interstitial
A115	MEDDRA-PT E33 Interstitial lung disease
A116	MEDDRA-PT-ID E33 10022611
A117	CUI E34 C0206062
A118	UMLS-Preferred-Name E34 Lung Diseases, Interstitial
A119	MEDDRA-PT E34 Interstitial lung disease
A120	MEDDRA-PT-ID E34 10022611
A121	CUI E35 C0206062
A122	UMLS-Preferred-Name E35 Lung Diseases, Interstitial
A123	MEDDRA-PT E35 Interstitial lung disease
A124	MEDDRA-PT-ID E35 10022611
A125	CUI E36 C1306577
A126	UMLS-Preferred-Name E36 Death (finding)
A127	MEDDRA-PT E36 Death
A128	MEDDRA-PT-ID E36 10011906
A129	CUI E39 C0855333
A130	UMLS-Preferred-Name E39 Electrocardiogram QT corrected interval prolonged
A131	MEDDRA-PT E39 Electrocardiogram QT prolonged
A132	MEDDRA-PT-ID E39 10014387
A133	LLT E39 Electrocardiogram QTc interval prolonged
A134	LLT-ID E39 10053698
A135	CUI E41 C2347725
A136	UMLS-Preferred-Name E41 QTcF Prolongation Greater Than 500 msec
A137	MEDDRA-PT E41 Electrocardiogram QT prolonged
A138	MEDDRA-PT-ID E41 10014387
A139	LLT E41 Electrocardiogram QTc interval prolonged
A140	LLT-ID E41 10053698
A141	CUI E42 C3828431
A142	UMLS-Preferred-Name E42 QTcF Prolongation
A143	MEDDRA-PT E42 Electrocardiogram QT prolonged
A144	MEDDRA-PT-ID E42 10014387
A145	LLT E42 Electrocardiogram QTc interval prolonged
A146	LLT-ID E42 10053698
A147	CUI E44 C0741627
A148	UMLS-Preferred-Name E44 BRADYCARDIA SYMPTOMATIC
A149	MEDDRA-PT E44 Bradycardia
A150	MEDDRA-PT-ID E44 10006093
A151	CUI E45 C0428977
A152	UMLS-Preferred-Name E45 Bradycardia
A153	MEDDRA-PT E45 Bradycardia
A154	MEDDRA-PT-ID E45 10006093
A155	CUI E46 C2230138
A156	UMLS-Preferred-Name E46 Pulse slow (finding)
A157	MEDDRA-PT E46 Heart rate decreased
A158	MEDDRA-PT-ID E46 10019301
A159	CUI E47 C0039070
A160	UMLS-Preferred-Name E47 Syncope
A161	MEDDRA-PT E47 Syncope
A162	MEDDRA-PT-ID E47 10042772
A163	CUI E49 C3887875
A164	UMLS-Preferred-Name E49 Visual field defects
A165	MEDDRA-PT E49 Visual field defect
A166	MEDDRA-PT-ID E49 10047555
A167	CUI E50 C3665386
A168	UMLS-Preferred-Name E50 Abnormal vision
A169	MEDDRA-PT E50 Blindness
A170	MEDDRA-PT-ID E50 10005169
A171	LLT E50 Vision loss
A172	LLT-ID E50 10047522
A173	CUI E52 C0029124
A174	UMLS-Preferred-Name E52 Optic Atrophy
A175	MEDDRA-PT E52 Optic atrophy
A176	MEDDRA-PT-ID E52 10030910
A177	CUI E53 C0029132
A178	UMLS-Preferred-Name E53 Disorder of the optic nerve
A179	MEDDRA-PT E53 Optic nerve disorder
A180	MEDDRA-PT-ID E53 10061322
A181	CUI E54 C3665386
A182	UMLS-Preferred-Name E54 Abnormal vision
A183	MEDDRA-PT E54 Blindness
A184	MEDDRA-PT-ID E54 10005169
A185	LLT E54 Vision loss
A186	LLT-ID E54 10047522
A187	CUI E56 C0854268
A188	UMLS-Preferred-Name E56 Foetal damage
A189	MEDDRA-PT E56 Foetal damage
A190	MEDDRA-PT-ID E56 10016852
A191	LLT E56 Fetal damage
A192	LLT-ID E56 10054743
A193	CUI E58 C0270009
A194	UMLS-Preferred-Name E58 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A195	MEDDRA-PT E58 Maternal drugs affecting foetus
A196	MEDDRA-PT-ID E58 10026923
A197	LLT E58 Drug toxicity NEC affecting foetus
A198	LLT-ID E58 10013750
A199	CUI E59 C0270009
A200	UMLS-Preferred-Name E59 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A201	MEDDRA-PT E59 Maternal drugs affecting foetus
A202	MEDDRA-PT-ID E59 10026923
A203	LLT E59 Drug toxicity NEC affecting foetus
A204	LLT-ID E59 10013750
A205	CUI E64 C0235378
A206	UMLS-Preferred-Name E64 Hepatotoxicity
A207	MEDDRA-PT E64 Hepatotoxicity
A208	MEDDRA-PT-ID E64 10019851
A209	CUI E65 C0428977
A210	UMLS-Preferred-Name E65 Bradycardia
A211	MEDDRA-PT E65 Bradycardia
A212	MEDDRA-PT-ID E65 10006093
A213	CUI E66 C0270009
A214	UMLS-Preferred-Name E66 Fetal or neonatal effect of toxic substance transmitted via placenta and/or breast milk
A215	MEDDRA-PT E66 Maternal drugs affecting foetus
A216	MEDDRA-PT-ID E66 10026923
A217	LLT E66 Drug toxicity NEC affecting foetus
A218	LLT-ID E66 10013750
